Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liver Failure Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Ornithine Phenylacetate
1.2.3 MTL-CEBPA
1.2.4 F-573
1.2.5 BL-1220
1.2.6 PP-100
1.2.7 Others
1.3 Market by Application
1.3.1 Global Liver Failure Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liver Failure Therapeutics Market Perspective (2019-2030)
2.2 Liver Failure Therapeutics Growth Trends by Region
2.2.1 Global Liver Failure Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Liver Failure Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Liver Failure Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Liver Failure Therapeutics Market Dynamics
2.3.1 Liver Failure Therapeutics Industry Trends
2.3.2 Liver Failure Therapeutics Market Drivers
2.3.3 Liver Failure Therapeutics Market Challenges
2.3.4 Liver Failure Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liver Failure Therapeutics Players by Revenue
3.1.1 Global Top Liver Failure Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Liver Failure Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Liver Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Liver Failure Therapeutics Revenue
3.4 Global Liver Failure Therapeutics Market Concentration Ratio
3.4.1 Global Liver Failure Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liver Failure Therapeutics Revenue in 2023
3.5 Liver Failure Therapeutics Key Players Head office and Area Served
3.6 Key Players Liver Failure Therapeutics Product Solution and Service
3.7 Date of Enter into Liver Failure Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Liver Failure Therapeutics Breakdown Data by Type
4.1 Global Liver Failure Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Liver Failure Therapeutics Forecasted Market Size by Type (2025-2030)
5 Liver Failure Therapeutics Breakdown Data by Application
5.1 Global Liver Failure Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Liver Failure Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Liver Failure Therapeutics Market Size (2019-2030)
6.2 North America Liver Failure Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Liver Failure Therapeutics Market Size by Country (2019-2024)
6.4 North America Liver Failure Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liver Failure Therapeutics Market Size (2019-2030)
7.2 Europe Liver Failure Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Liver Failure Therapeutics Market Size by Country (2019-2024)
7.4 Europe Liver Failure Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liver Failure Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Liver Failure Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Liver Failure Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Liver Failure Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liver Failure Therapeutics Market Size (2019-2030)
9.2 Latin America Liver Failure Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Liver Failure Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Liver Failure Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liver Failure Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Liver Failure Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Liver Failure Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Liver Failure Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alfact Innovation
11.1.1 Alfact Innovation Company Detail
11.1.2 Alfact Innovation Business Overview
11.1.3 Alfact Innovation Liver Failure Therapeutics Introduction
11.1.4 Alfact Innovation Revenue in Liver Failure Therapeutics Business (2019-2024)
11.1.5 Alfact Innovation Recent Development
11.2 BioLineRx Ltd
11.2.1 BioLineRx Ltd Company Detail
11.2.2 BioLineRx Ltd Business Overview
11.2.3 BioLineRx Ltd Liver Failure Therapeutics Introduction
11.2.4 BioLineRx Ltd Revenue in Liver Failure Therapeutics Business (2019-2024)
11.2.5 BioLineRx Ltd Recent Development
11.3 Cell2B Advanced Therapeutics SA
11.3.1 Cell2B Advanced Therapeutics SA Company Detail
11.3.2 Cell2B Advanced Therapeutics SA Business Overview
11.3.3 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Introduction
11.3.4 Cell2B Advanced Therapeutics SA Revenue in Liver Failure Therapeutics Business (2019-2024)
11.3.5 Cell2B Advanced Therapeutics SA Recent Development
11.4 Conatus Pharmaceuticals Inc
11.4.1 Conatus Pharmaceuticals Inc Company Detail
11.4.2 Conatus Pharmaceuticals Inc Business Overview
11.4.3 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Introduction
11.4.4 Conatus Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2019-2024)
11.4.5 Conatus Pharmaceuticals Inc Recent Development
11.5 Immune Pharmaceuticals Inc
11.5.1 Immune Pharmaceuticals Inc Company Detail
11.5.2 Immune Pharmaceuticals Inc Business Overview
11.5.3 Immune Pharmaceuticals Inc Liver Failure Therapeutics Introduction
11.5.4 Immune Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2019-2024)
11.5.5 Immune Pharmaceuticals Inc Recent Development
11.6 Mina Therapeutics Ltd
11.6.1 Mina Therapeutics Ltd Company Detail
11.6.2 Mina Therapeutics Ltd Business Overview
11.6.3 Mina Therapeutics Ltd Liver Failure Therapeutics Introduction
11.6.4 Mina Therapeutics Ltd Revenue in Liver Failure Therapeutics Business (2019-2024)
11.6.5 Mina Therapeutics Ltd Recent Development
11.7 Mylan NV
11.7.1 Mylan NV Company Detail
11.7.2 Mylan NV Business Overview
11.7.3 Mylan NV Liver Failure Therapeutics Introduction
11.7.4 Mylan NV Revenue in Liver Failure Therapeutics Business (2019-2024)
11.7.5 Mylan NV Recent Development
11.8 Ocera Therapeutics Inc
11.8.1 Ocera Therapeutics Inc Company Detail
11.8.2 Ocera Therapeutics Inc Business Overview
11.8.3 Ocera Therapeutics Inc Liver Failure Therapeutics Introduction
11.8.4 Ocera Therapeutics Inc Revenue in Liver Failure Therapeutics Business (2019-2024)
11.8.5 Ocera Therapeutics Inc Recent Development
11.9 PledPharma AB
11.9.1 PledPharma AB Company Detail
11.9.2 PledPharma AB Business Overview
11.9.3 PledPharma AB Liver Failure Therapeutics Introduction
11.9.4 PledPharma AB Revenue in Liver Failure Therapeutics Business (2019-2024)
11.9.5 PledPharma AB Recent Development
11.10 Promethera Biosciences SA
11.10.1 Promethera Biosciences SA Company Detail
11.10.2 Promethera Biosciences SA Business Overview
11.10.3 Promethera Biosciences SA Liver Failure Therapeutics Introduction
11.10.4 Promethera Biosciences SA Revenue in Liver Failure Therapeutics Business (2019-2024)
11.10.5 Promethera Biosciences SA Recent Development
11.11 Silence Therapeutics Plc
11.11.1 Silence Therapeutics Plc Company Detail
11.11.2 Silence Therapeutics Plc Business Overview
11.11.3 Silence Therapeutics Plc Liver Failure Therapeutics Introduction
11.11.4 Silence Therapeutics Plc Revenue in Liver Failure Therapeutics Business (2019-2024)
11.11.5 Silence Therapeutics Plc Recent Development
11.12 Unicyte AG
11.12.1 Unicyte AG Company Detail
11.12.2 Unicyte AG Business Overview
11.12.3 Unicyte AG Liver Failure Therapeutics Introduction
11.12.4 Unicyte AG Revenue in Liver Failure Therapeutics Business (2019-2024)
11.12.5 Unicyte AG Recent Development
11.13 Ventria Bioscience
11.13.1 Ventria Bioscience Company Detail
11.13.2 Ventria Bioscience Business Overview
11.13.3 Ventria Bioscience Liver Failure Therapeutics Introduction
11.13.4 Ventria Bioscience Revenue in Liver Failure Therapeutics Business (2019-2024)
11.13.5 Ventria Bioscience Recent Development
11.14 Vital Therapies Inc
11.14.1 Vital Therapies Inc Company Detail
11.14.2 Vital Therapies Inc Business Overview
11.14.3 Vital Therapies Inc Liver Failure Therapeutics Introduction
11.14.4 Vital Therapies Inc Revenue in Liver Failure Therapeutics Business (2019-2024)
11.14.5 Vital Therapies Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details